Research Progress of Metronomic Chemotherapy in the Treatment of Elderly Cancer Patients

In China, elderly individuals (≥60 years) face a growing cancer burden, accounting for 55.8% of new cases and 68.2% of deaths. Metronomic chemotherapy offers a promising approach by using continuous low-dose treatment to inhibit tumor growth with fewer side effects. breaking through the cycle-dependent limitations of traditional chemotherapy, this review discusses its applications and benefits for elderly cancer patients, aiming to support clinical practice, at the same time, significantly improves patient compliance and the quality of life of elderly patients.